Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
11/2000
11/22/2000EP1053677A1 Nonhuman animal embryonic stem cells and nonhuman animals having variant smooth muscle myosin heavy-chain genes
11/22/2000EP1053356A2 Method for diagnosis and treatment of disorders of carbohydrate metabolism
11/22/2000EP1053351A1 Novel molecules of the tnf receptor superfamily and uses therefor
11/22/2000EP1053343A2 Targeting of genetic vaccine vectors
11/22/2000EP1053341A1 Use of negative regulation elements for nerve-specific expression of transgenes
11/22/2000EP1053337A1 Nucleic acid comprising the sequence of a promoter inductible by stress and a gene sequence coding for a stilbene synthase
11/22/2000EP1053336A1 Promoter inductible in plants, sequence incorporating same and resulting product
11/22/2000EP1053332A1 Protein
11/22/2000EP1053331A2 A novel fungal protein critical for expression of fungal proteins
11/22/2000EP1053324A1 Novel cystine knot protein and materials and methods for making it
11/22/2000EP1053321A1 Novel tumor necrosis factor receptor homolog and nucleic acids encoding the same
11/22/2000EP1053320A2 Human transport-associated molecules
11/22/2000EP1053319A2 Human genes and gene expression products ii
11/22/2000EP1053318A2 Cdnas encoding secreted proteins
11/22/2000EP1053312A2 Optimization of immunomodulatory properties of genetic vaccines
11/22/2000EP1053309A1 Compositions and methods for wound healing
11/22/2000EP1053308A1 Dendritic enriched secreted lymphocyte activation molecule
11/22/2000EP1053306A1 Secreted proteins and polynucleotides encoding them
11/22/2000EP1053302A2 Expanded and genetically modified populations of human hematopoietic stem cells
11/22/2000EP1053301A1 A universal immunomodulatory cytokine-expressing bystander cell line and related compositions and methods of manufacture and use
11/22/2000EP1053256A1 Antibodies to death receptor 4 (dr4) and uses thereof
11/22/2000EP1053253A1 Novel gaba b? receptor dna sequences
11/22/2000EP1053251A1 The aiolos gene
11/22/2000EP1053245A1 45 human secreted proteins
11/22/2000EP1053007A2 Methods and compositions for modulating leptin activity
11/22/2000EP1053005A2 Method of promoting keratinocyte proliferation
11/22/2000EP1053004A2 Use of angiotensin analogues for promoting erythropoiesis
11/22/2000EP1053002A1 Treatment of bony defects with osteoblast precursor cells
11/22/2000EP0971580A4 Regulatory element for expressing genes in plants
11/22/2000EP0871885A4 Attachment enhanced 293 cells
11/22/2000EP0866850A4 Auxinic analogues of indole-3-acetic acid
11/22/2000EP0703988B1 Mesothelial cell gene therapy
11/22/2000CN1274388A Mutated barnase gene and plant transformed by same
11/22/2000CN1274387A HCVE mimotopes of hypervariable region 1 and uses
11/22/2000CN1274386A Genetic control of plant growth and develepmnt
11/22/2000CN1274290A Vaccination by topical application of genetic vectors
11/22/2000CN1274260A Hypersensitive response elicitor from i(Erwinia Amylovora) and its use
11/22/2000CN1274259A Hypersensitive response elicitor from i(pseudomonas syringae) and its use
11/21/2000US6150583 Transgenic animals expressing artificial epitope-tagged proteins
11/21/2000US6150505 Preparing aqueous solution of fibrinogen, thrombin and factor xiii, before coagulation adding an oil heated to 50-80 degrees celsius to form emulsion, mixing until crosslinked microbeads are formed, isolating beads; glutaraldehyde-free
11/21/2000US6150502 Polypeptides expressed in skin cells
11/21/2000US6150345 Methods for promoting survival of myelin producing cells
11/21/2000US6150340 RNA-dependent amidotransferase from Staphylococcus aureus
11/21/2000US6150338 Delivery and expression of a recombinant vector containing a dna sequence encoding a protein involved in the regulation of smooth muscle tone into a smooth muscle cell
11/21/2000US6150326 Means for treating autoimmune diseases and method for the treatment thereof
11/21/2000US6150169 Inserting a coding sequence into a target endogenous gene in a mouse embryonic stem cell genome by transforming with vector having specific dna construct and allowing homologous recombination
11/21/2000US6150167 Method of determining conifer embryo maturity using sugar alcohol content
11/21/2000US6150166 System for propagating in vitro tissue cultures of a plant species
11/21/2000US6150164 Methods and compositions of a bioartificial kidney suitable for use in vivo or ex vivo
11/21/2000US6150163 Enhancing the rate of re-differentiation of passaged, de-differentiated human articular chondrocytes by culturing in medium supplemented with transforming growth factor-beta and insulin-like growth factor or insulin
11/21/2000US6150156 Bacillus thuringiensis isolates active against sucking insects
11/21/2000US6150134 Recombinant microorganism polypeptide; for the diagnosis, treatment and prevention of preferential microorganismal infections; for the purification of recombinant polypeptides
11/21/2000US6150132 Vector coding polypeptides for the diagnosis and treatment of allergies and atherosclerosis; for the prevention of graft ejection and injuries to stem cell caused by anticarcinogenic agents
11/21/2000US6150125 Flea protease proteins and uses thereof
11/21/2000US6150116 Transcription factor DP-1 antibody
11/21/2000US6150114 Method and reagent for monitoring blood levels of antiplantelet compounds
11/21/2000US6150101 Methods of identifying a composition that alters connective tissue growth factor expression
11/21/2000US6150099 Detecting modulators of transcription factors; incubating transcription factor and modulator in solution, monitor the level of gene expression
11/21/2000US6150093 Unique associated Kaposi's sarcoma virus sequences and uses thereof
11/21/2000US6149919 Immunogenic detoxified mutants of cholera toxin and of the toxin LT, their preparation and their use for the preparation of vaccines
11/21/2000US6149907 Treatments using sertoli cells
11/21/2000US6149906 Activation of t-lymphocytes and induction of antigen-specific immune responses; preventing, treating various diseases ( viral, bacterial, fungal), botulism toxin, poison ivy, poison sumac
11/21/2000US6149905 Administering a modifying tumor cells from a mammalian subject to express a b7 molecule; preventing or inhibiting metastatic spread of a tumor
11/21/2000US6149902 Manipulation of non-terminally differentiated cells using the notch pathway
11/21/2000US6149867 Sheath fluids and collection systems for sex-specific cytometer sorting of sperm
11/16/2000WO2000068687A2 Methods of identifying therapeutic compounds in a genetically defined setting
11/16/2000WO2000068433A2 Autism gene
11/16/2000WO2000068414A2 Whole cell assay for cathepsin k
11/16/2000WO2000068411A1 Compositions and methods for enhanced sensitivity and specificity of nucleic acid synthesis
11/16/2000WO2000068399A2 Vector-mediated delivery of integrating transposon sequences
11/16/2000WO2000068396A2 Bacillus circulans xylanase mutants
11/16/2000WO2000068394A1 Epoxide hydrolases of aspergillus origin
11/16/2000WO2000068387A2 Nucleic acids and proteins with interferon-beta activity
11/16/2000WO2000068386A1 Autotaxin variants and uses to treat diseases of metabolism
11/16/2000WO2000068385A2 Novel nucleic acids and proteins with growth hormone activity
11/16/2000WO2000068384A2 NOVEL NUCLEIC ACIDS AND PROTEINS WITH p53 ACTIVITY AND ALTERED TETRAMERIZATION DOMAINS
11/16/2000WO2000068383A2 Family of immunoregulators designated leukocyte immunoglobulin-like receptors (lir)
11/16/2000WO2000068382A1 PrP-LIKE GENE
11/16/2000WO2000068381A1 Cytokine receptor mouse zcytor10
11/16/2000WO2000068380A2 Extracellular matrix and adhesion-associated proteins
11/16/2000WO2000068379A1 Methods for treating tumors using antiangiogenic compounds
11/16/2000WO2000068376A1 Novel chimpanzee erythropoietin (chepo) polypeptides and nucleic acids encoding the same
11/16/2000WO2000068374A1 Regulation of viral gene expression
11/16/2000WO2000068370A2 ib00180US MAIS
11/16/2000WO2000068362A2 Undifferentiated erythroid cells and their use in ligand binding assays
11/16/2000WO2000068361A1 Versican and epithelial-mesenchymal interaction
11/16/2000WO2000068359A1 Lineage-restricted precursor cells isolated from mouse neural tube and mouse embryonic stem cells
11/16/2000WO2000068270A1 Antibodies and peptides for detection of plasmodium vivax
11/16/2000WO2000068268A1 Human gabab receptor 1 promoters
11/16/2000WO2000068263A2 Stereoselective antifibrillogenic peptides and peptidomimetics thereof
11/16/2000WO2000068258A2 Compounds exhibiting an antibiotic activity
11/16/2000WO2000068247A2 Serine proteases
11/16/2000WO2000068243A1 Methods using mechanisms of action of aroa
11/16/2000WO2000067815A1 A tissue engineering scaffold
11/16/2000WO2000067814A1 Biostability of polymeric structures
11/16/2000WO2000067813A1 Biostable polyurethane products
11/16/2000WO2000067792A1 Monoclonal antibody directed against cells of human renal cell carcinoma
11/16/2000WO2000067761A1 Compositions and methods for identifying antigens which elicit an immune response
11/16/2000WO2000067700A2 Recombinant vaccine against botulinum neurotoxin
11/16/2000WO2000067672A2 Tissue engineering for making tubular implants
1 ... 1468 1469 1470 1471 1472 1473 1474 1475 1476 1477 1478 1479 1480 1481 1482 1483 1484 1485 1486 1487 1488 ... 1827